Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates.
Multiple sclerosis in Syria.
Internet-delivered lifestyle physical activity intervention improves body composition in multiple sclerosis: Preliminary evidence from a randomized controlled trial.
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Transanal irrigation for bowel symptoms in patients with multiple sclerosis.
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.
Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica.
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
[Microglia in pathophysiology of neuroimmunological disorders].
Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications.
Contribution of MicroRNAs to autoimmune diseases.
[Spinal segmental myoclonus in multiple sclerosis (case report).]
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging.
Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Chromosomal radiosensitivity in patients with multiple sclerosis.
P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown.
Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Pages
« first
‹ previous
…
279
280
281
282
283
284
285
286
287
…
next ›
last »